CCAP vs. UPST, IREN, CORZ, PWP, LU, CIFR, SII, WULF, BITF, and ML
Should you be buying Crescent Capital BDC stock or one of its competitors? The main competitors of Crescent Capital BDC include Upstart (UPST), Iris Energy (IREN), Core Scientific (CORZ), Perella Weinberg Partners (PWP), Lufax (LU), Cipher Mining (CIFR), Sprott (SII), TeraWulf (WULF), Bitfarms (BITF), and MoneyLion (ML). These companies are all part of the "nondepository credit institutions" industry.
Upstart (NASDAQ:UPST) and Crescent Capital BDC (NASDAQ:CCAP) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, community ranking, risk, institutional ownership and earnings.
63.0% of Upstart shares are held by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are held by institutional investors. 18.1% of Upstart shares are held by insiders. Comparatively, 1.1% of Crescent Capital BDC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Upstart had 8 more articles in the media than Crescent Capital BDC. MarketBeat recorded 13 mentions for Upstart and 5 mentions for Crescent Capital BDC. Upstart's average media sentiment score of 0.73 beat Crescent Capital BDC's score of -0.03 indicating that Crescent Capital BDC is being referred to more favorably in the news media.
Upstart currently has a consensus target price of $21.65, indicating a potential downside of 11.96%. Crescent Capital BDC has a consensus target price of $18.75, indicating a potential downside of 0.21%. Given Upstart's stronger consensus rating and higher probable upside, analysts clearly believe Crescent Capital BDC is more favorable than Upstart.
Upstart has a beta of 2.01, suggesting that its stock price is 101% more volatile than the S&P 500. Comparatively, Crescent Capital BDC has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.
Crescent Capital BDC has a net margin of 53.32% compared to Crescent Capital BDC's net margin of -32.59%. Upstart's return on equity of 11.99% beat Crescent Capital BDC's return on equity.
Crescent Capital BDC has lower revenue, but higher earnings than Upstart. Upstart is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.
Upstart received 18 more outperform votes than Crescent Capital BDC when rated by MarketBeat users. However, 55.56% of users gave Crescent Capital BDC an outperform vote while only 32.21% of users gave Upstart an outperform vote.
Summary
Crescent Capital BDC beats Upstart on 11 of the 18 factors compared between the two stocks.
Get Crescent Capital BDC News Delivered to You Automatically
Sign up to receive the latest news and ratings for CCAP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Crescent Capital BDC Competitors List
Related Companies and Tools
